Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Strut Health vs Vytora Health

Strut Health
Graded #21

Higher grade

vs+9.700000000000003
Vytora Health
Graded #79

Lower grade

The verdict

Strut Health takes it — 82/100 to 72.3/100.

Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueStrut Health +31
90
59
Dose & formulationStrut Health +10
95
85
Clinical oversightVytora Health +28
68
96
Labs & monitoringStrut Health +5
60
55
FulfillmentVytora Health +8
88
96
Contract termsStrut Health +72
92
20
Strut Health · left barVytora Health · right bar

The numbers

MetricStrut HealthVytora Health
WeighScore82/10072.3/100
GradeB−C
Scorecard rank#21#79
SemaglutideFrom $99/mo sublingual, $149/mo injectable$180/mo (all doses, compounded)
TirzepatideFrom $199/mo either route$249/mo (all doses, compounded)
Coverage49 states (not Arkansas)All 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Strut Health

Graded #21 · B−

Strengths

  • Sublingual lozenges for both molecules at the same price as the injection — semaglutide from $99/mo, tirzepatide from $199/mo
  • Every route and auto-refill saving published on the product page rather than inside an intake
  • Free physician visit, free shipping and free follow-up care included
  • Cancel, pause or delay yourself with 48 hours' notice

Where it loses points

  • Asynchronous by design — some states need no phone consultation, so you may never speak to the prescriber
  • No published lab or monitoring programme
  • Compounded only, with no brand-name lane
  • Not available in Arkansas
Vytora Health

Graded #79 · C

Strengths

  • All 50 states plus DC, with per-state video-vs-audio compliance disclosed
  • Both compounded and brand-name options on one platform — uncommon
  • LegitScript Approved and HIPAA compliant
  • Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
  • Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)

Where it loses points

  • Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
  • Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
  • Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
  • Initial consultation cost not shown on the public pricing page
  • Limited per-prescriber state licensure detail

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard